KAMIREN

This brand name is authorized in Estonia, Hong Kong, Croatia, Ireland, Lithuania, Poland, Romania

Active ingredients

The drug KAMIREN contains one active pharmaceutical ingredient (API):

1 Doxazosin UNII 86P6PQK0MU - DOXAZOSIN MESYLATE

Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure. Read about Doxazosin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KAMIREN Prolonged-release tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02CA04	Doxazosin	C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1071379, 1071380, 1071391, 1156261, 1156272, 1156283, 1156294
Country: HK	Department of Health Drug Office	Identifier(s): 60181
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-366773352, HR-H-708601380, HR-H-868744606
Country: IE	Health Products Regulatory Authority	Identifier(s): 14585
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003365, 1003366, 1004329, 1019586, 1019587, 1019588, 1019589, 1019790, 1019791, 1019792
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100094653, 100094660, 100120847
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W08648001, W08648002, W08649001, W08649002